Beyond Air, Inc.
About Beyond Air, Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $3.7M
- Net income
- -$46.6M
- Total assets
- $30.1M
- Market cap
- $5.2M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $5.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 27, 2016
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Beyond Air, Inc..